Other reports have also shown that increased anti-inflammatory cytokines like IL-10 and TGF-β can help Tregs suppress the function of antigen-presenting cells and arrest the activation of effector T lymphocytes during tumor progression [2], [35], [36]. The gene discussed is TGFB1; the disease is neoplasm.